Published in Acta Pathol Microbiol Scand B Microbiol Immunol on January 01, 1971
Absence of immunoreactive interferon-alpha in CSF from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (1986) 0.78
Immunoreactive IFN-gamma in CSF in neurological disorders. J Neurol Neurosurg Psychiatry (1987) 0.76
Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons. J Immunol (1975) 2.09
Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus. Infect Immun (1976) 1.67
Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) (1982) 1.59
A randomized, double-blind, placebo-controlled MRI study of anti-herpes virus therapy in MS. Neurology (2002) 1.56
Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies. Infect Immun (1977) 1.11
Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol (2003) 1.06
The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients? Acta Neurol Scand (1998) 0.92
Cell-mediated and humoral immunity to herpesviruses during and after herpes zoster infections. Infect Immun (1980) 0.91
Pleural effusion disease in rabbits. Interferon in body fluids and tissues after experimental infection. Acta Pathol Microbiol Scand B (1979) 0.90
Cellular and humoral immune responses to herpes simplex virus during and after primary gingivostomatitis. Infect Immun (1978) 0.88
Humoral and cell-mediated immune responses in humans before and after revaccination with vaccinia virus. Infect Immun (1978) 0.88
The occurrence of interferon in the cerebrospinal fluid in patients with bacterial meningitis. Acta Pathol Microbiol Scand (1968) 0.87
Molecular characterization of HERV-H variants associated with multiple sclerosis. Acta Neurol Scand (2000) 0.86
Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: associations with disease activity. Acta Neurol Scand (2005) 0.86
The occurrence of virus and interferon in spleen, serum and brain in steroi-treated mice under experimental infection with West Nile virus. Acta Pathol Microbiol Scand (1969) 0.85
B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Mult Scler (1995) 0.85
Cellular and humoral immunity in Hodgkin's disease. I Patients in continuous long-term remission. Scand J Haematol (1981) 0.83
Cell-mediated and humoral immune responses to herpes simplex virus and cytomegalovirus in renal transplant patients. J Clin Microbiol (1979) 0.83
Just another dubious virus in cells from a patient with multiple sclerosis? Lancet (1991) 0.83
X-linked resistance of mice to high doses of herpes simplex virus type 2 correlates with early interferon production. Infect Immun (1983) 0.81
Poikilothermia and susceptibility of suckling mice to Coxsackie B1 virus. Nature (1974) 0.80
Lymphocyte-mediated cytotoxicity in humans during revaccination with vaccinia virus. Infect Immun (1978) 0.80
Abolished production of interferon by leucocytes of patients with the acquired cytogenetic abnormalities 5q -- or -- 5 in secondary and de-novo acute non-lymphocytic leukaemia. Br J Haematol (1980) 0.80
A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand (1998) 0.80
The influence of Poly I:C on the course of infection in mice inoculated with West Nile virus. Arch Gesamte Virusforsch (1971) 0.80
The influence of different temperatures on mortality, virus multiplication and interferon production in adult mice infected with Coxsackie B1 virus. Arch Gesamte Virusforsch (1973) 0.79
The influence of hyperthermia and poly I:C on Semliki Forest virus infection in mice. Arch Virol (1975) 0.79
Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol Scand Suppl (1997) 0.79
Function of fever. Lancet (1977) 0.79
Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group. Clin Exp Immunol (1983) 0.79
Interferon induction, 2'-5' oligo A synthetase and lymphocyte subpopulations in out-patients with multiple sclerosis in a longitudinal study. Acta Neurol Scand (1986) 0.78
The occurrence of virus and interferon in the spleen, serum and brain in mice after experimental infection with West Nile virus. Acta Pathol Microbiol Scand (1968) 0.78
The implications of Epstein-Barr virus in multiple sclerosis--a review. Acta Neurol Scand Suppl (1997) 0.78
The possible role of circulating interferon on autointerference in mice infected intraperitoneally with West Nile virus. Acta Pathol Microbiol Scand (1969) 0.77
Late-onset rubella syndrome: coexistence of immune complex disease and defective cytotoxic effector cell function. Clin Exp Immunol (1986) 0.77
Cluster of multiple sclerosis patients from Danish community. Lancet (1997) 0.77
The phagocytic activity of monocytes and polymorphonuclear leucocytes against viral antigens as measured by chemiluminescence in patients with multiple sclerosis. J Clin Lab Immunol (1989) 0.76
Retrovirus-like particles in an Epstein-Barr virus-producing cell line derived from a patient with chronic progressive myelopathy. Acta Neurol Scand (1993) 0.75
MS and the group-specific component. Acta Neurol Scand (1988) 0.75
In vitro susceptibilities of normal human skin fibroblasts to oncoviruses, and the decreased susceptibility to HSV of fibroblasts from untreated Hodgkin's patients. Br J Cancer (1981) 0.75
Interferon in rabbit sera after inoculation with Treponema pallidum suspensions contaminated with PED virus. Br J Vener Dis (1982) 0.75
Function of fever in infectious disease. Biomedicine (1978) 0.75
Cellular immunity to herpes simplex infection in humans. Surv Ophthalmol (1976) 0.75
The influence of general anesthesia and surgery on cell-mediated cytotoxicity and interferon production. J Clin Lab Immunol (1983) 0.75
The effects of antilymphocyte serum on viraemia and serum interferon of mic3e infected with West Nile virus. Acta Pathol Microbiol Scand (1969) 0.75
A retroviral implication in multiple sclerosis? Trends Microbiol (1994) 0.75
Search for a retrovirus in long-term cultured cerebrospinal fluid cells and peripheral blood mononuclear cells from patients with multiple sclerosis. Acta Neurol Scand (1989) 0.75
Hodgkin's disease: in vitro susceptibility of skin fibroblasts to infection with virus and to lysis by autologous lymphocytes. Tokai J Exp Clin Med (1983) 0.75
[Fever, hypothermia and hyperthermia in virus infections]. Ugeskr Laeger (1979) 0.75
Cellular immunity in herpes simplex and cytomegalovirus infections in renal allograft recipients. Proc Eur Dial Transplant Assoc (1979) 0.75
The influence of human allergic encephalitogenic peptide on cell-mediated cytotoxicity reactions in patients with multiple sclerosis. J Neuroimmunol (1987) 0.75
[Virus as the cause of disseminated sclerosis?]. Ugeskr Laeger (1986) 0.75
[A comparative stydy of the Paul-Bunnell reaction and the EMNI-test]. Ugeskr Laeger (1968) 0.75
Interferon production, cellular and humoral immunity in splenectomized patients. Scand J Haematol (1982) 0.75
Tubuloreticular inclusions in skin biopsies from patients with HIV infection. APMIS (1989) 0.75
[Neonatal Herpes simplex virus infection treated with hyperthermia]. Ugeskr Laeger (1979) 0.75
[Intermittent high pressure ventilation used as a treatment of chronic lung diseases]. Ugeskr Laeger (1965) 0.75
Use of purified cytomegalovirus as antigen in the complememt fixation test. Scand J Infect Dis (1977) 0.75
[Interferons]. Ugeskr Laeger (1977) 0.75
[New knowledge on the pathogenesis of multiple sclerosis]. Ugeskr Laeger (1990) 0.75
[Disseminated sclerosis and retrovirus]. Ugeskr Laeger (1992) 0.75